Factors Influencing Ki67 Calculation in Neuroendocrine Neoplasia
Carlos A. Castañeda(Instituto Nacional de Enfermedades Neoplásicas), Yun Wu(The University of Texas MD Anderson Cancer Center), Luis Cano(Instituto Nacional de Enfermedades Neoplásicas), Miluska Castillo(Instituto Nacional de Enfermedades Neoplásicas), Rosario Villa-Robles(Instituto Nacional de Enfermedades Neoplásicas), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Claudio Flores(EsSALUD), Juvenal Sánchez(Instituto Nacional de Enfermedades Neoplásicas), Gabriela Rios-Martini(Instituto Nacional de Enfermedades Neoplásicas), Carlos Gonzalez(Instituto Nacional de Enfermedades Neoplásicas), Carolina Belmar-López(Instituto Nacional de Enfermedades Neoplásicas)
Cited by 0
Related Papers
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
|Science Translational Medicine|2019|316
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
|npj Breast Cancer|2021|282
Malignant Gliomas with Primitive Neuroectodermal Tumor‐like Components: A Clinicopathologic and Genetic Study of 53 Cases
|Brain Pathology|2008|178
The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
|Cancer and Metastasis Reviews|2010|171